Effect of Hyaluronidase on Intraocular Pressure
Overview
The aim of this study is to evaluate effect of retrobulbar local anaesthesia after addition of hyaluronidase on IOP during cataract surgery
Full Title of Study: “Effect of Hyaluronidase on Intraocular Pressure After Retrobulbar Anaesthesia During Cataract Surgery”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: N/A
- Intervention Model: Single Group Assignment
- Primary Purpose: Diagnostic
- Masking: None (Open Label)
- Study Primary Completion Date: September 2018
Interventions
- Drug: Hyaluronidase
- 4ml of retrobulbar LA with addition of 15IU/ml hyaluronidase to 2% lidocaine
Arms, Groups and Cohorts
- Experimental: Effect of hyaluronidase on IOP
Clinical Trial Outcome Measures
Primary Measures
- reduction in IOP
- Time Frame: within 10minutes
- reduction of complications of high IOP during surgery
Participating in This Clinical Trial
Inclusion Criteria
- 1-Patients above the age of 50 years. 2-Patients with age related cataract. 3-Normal IOP. Exclusion Criteria:
- 1History of trauma. 2-Patients with glaucoma. 3-Previous ocular surgery. 4-Patients with other ocular pathology. 5-Uncontrolled diabetes or hypertension. 6-hypersensitivity to lignocaine. 7-Uncooperative or epileptic patients.
Gender Eligibility: All
Minimum Age: 50 Years
Maximum Age: 80 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Assiut University
- Provider of Information About this Clinical Study
- Principal Investigator: Eman Yassin Ahmed, Principal Investigator – Assiut University
- Overall Contact(s)
- Eman Yassin, 00201004686028, emanyassin08@gmail.com
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.